Comparative proteome analysis to explore p53 pathway disruption in head and neck carcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Head and neck squamous cell carcinoma (HNSCC) survival rates show limited improvement.
• HNSCC originates from asymptomatic, genetically altered mucosal fields with p53 pathway disruption.
• Undetected precursor fields post-surgery can lead to secondary tumors, highlighting the need for early detection biomarkers.

Purpose of the Study:

• To identify differential proteins associated with p53 pathway dysfunction in HNSCC.
• To discover novel biomarkers for predicting the presence of HNSCC precursor fields.
• To improve early detection and management strategies for HNSCC.

Main Methods:

• Utilized a squamous cell model with inactivated p53.
• Employed 2D-Differential Gel Electrophoresis (2D-DIGE) and Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS) for protein analysis.
• Validated differential protein expression using immunohistochemical staining.

Main Results:

• Identified a set of 74 differentially expressed proteins between cells with normal and disrupted p53 function.
• Six proteins showed significant expression changes, with peroxiredoxin-1 being a key finding.
• Peroxiredoxin-1 demonstrated immunohistochemical ability to distinguish normal epithelium from TP53-mutated precursor field tissue.

Conclusions:

• Peroxiredoxin-1 is a promising biomarker for identifying HNSCC precursor fields with TP53 mutations.
• This discovery can facilitate targeted screening and early detection of HNSCC.
• The identified proteins may enhance understanding and management of HNSCC progression.